Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Why Amplia Therapeutics (ASX:ATX) Is in a Trading Halt: What Biotech Investors Should Know?

Pancreatic cancer remains one of oncology's most challenging indications, with 5-year survival rates hovering around 10%. Any therapy demonstrating meaningful improvement in response rates or overall survival generates significant investor interest. Early interim data from ACCENT has already shown promise: a 35% confirmed response …

Sonal Goyal | 19 March 2026

EBR Systems (ASX:EBR) Draws Focus as WiSE Technology Targets Disruption in Cardiac Pacing Market

EBR Systems (ASX:EBR) represents a unique investment opportunity in medical device innovation, developing and commercializing the world's first and only wireless cardiac pacing system designed specifically for cardiac resynchronization therapy (CRT) patients. Q4 2025 quarterlycash flowreporting demonstrates that the Silicon Valley-based company is successfully …

Team Kalkine | 19 March 2026

Mach7 Technologies (ASX:M7T) Shares Under Pressure Amid Tech Sector Weakness

The stock closed at A$0.28, with tradingvolumereaching 276,038 shares. The trading volume indicates active selling pressure across the market. As one of the most significant movers on theASXtoday, M7T has become a focal point for investors evaluating opportunities in the Australian share market.

Team Kalkine | 19 March 2026

Proteomics International Laboratories  (ASX: PIQ) Declined on Diagnostics Sector Challenges

The stock closed at A$0.310, with trading volume reaching 304.82K shares. The trading volume indicates active selling pressure across the market. As one of the most significant movers on the ASX today, PIQ has become a focal point for investors evaluating opportunities in the …

Aditi Sarkar | 19 March 2026

How Are Regulatory and Market Headwinds Impacting NOVONIX’s (ASX:NVX) Share Price?

NOVONIX Limited (ASX:NVX) operates at the heart of one of the most important industrial transformations of the 21st century—the global shift toward electrification and energy storage. As a producer of synthetic graphite anode materials used in lithium-ion batteries, the company is directly exposed to …

Sonal Goyal | 18 March 2026

Telix Pharmaceuticals (ASX:TLX): Is This 7.3% Surge Reflecting a Breakout in High-Growth Healthcare Innovation?

Telix Pharmaceuticals Limited (ASX:TLX) has climbed 7.39% to AUD 12.57, reinforcing its position as one of the most closely watched healthcare technology stocks on theASX. Unlike resource companies driven bycommoditycycles, Telix operates in the high-growth, high-risk biotechnology sector, where valuation is shaped by innovation, …

Sonal Goyal | 18 March 2026

NTI Stock in Focus: Neurotech International Starts Phase 3 Trial at Leading Hospital

The first site to be activated is Monash Children's Hospital, one of Australia's leading paediatric medical and research facilities. The site is now open for patient screening and recruitment, representing the beginning of what could be a transformational clinical program for the company.

Aditi Sarkar | 17 March 2026

Vitura Health (ASX:VIT) Gains Momentum on New Commercial Distribution Agreement

Vitura Health Ltd (ASX:VIT) shares increased 5.13% to AUD 0.041 on 17 March 2026 after the company announced a new commercial distribution agreement with MedReleaf Australia. Despite today’s gain, the stock remains down 41.43% over the past year, reflecting broader pressure over the period. …

Team Kalkine | 17 March 2026

Why Black Canyon (ASX:BCA) Stock Fell Today Despite Killer Manganese Met Results

Black Canyon Limited (ASX:BCA), a Pilbara-focused manganese explorer, saw its shares retreat 6.78% to $0.275 on March 17, 2026, despite positive metallurgical testwork from its flagship Wandanya Project signaling direct shipping ore (DSO) potential. Volume of 177,916 shares reflected active trading, with the stock'smarket …

Sonal Goyal | 17 March 2026

From CSL to Telix: Understanding the Drivers Behind Healthcare Sector Weakness

The healthcare sector has traditionally been viewed as a defensive component of the ASX, offering stability during periods of economic uncertainty. However, recent performance has challenged this perception, with several major healthcare stocks experiencing significant declines.

Aditi Sarkar | 17 March 2026
Support

Hi! How can we help you today?

Loading…